Cargando…
Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413032/ https://www.ncbi.nlm.nih.gov/pubmed/37577324 http://dx.doi.org/10.21037/tlcr-23-329 |
| _version_ | 1785087046418694144 |
|---|---|
| author | Ulas, Ezgi B. Bahce, Idris |
| author_facet | Ulas, Ezgi B. Bahce, Idris |
| author_sort | Ulas, Ezgi B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10413032 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104130322023-08-11 Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? Ulas, Ezgi B. Bahce, Idris Transl Lung Cancer Res Editorial AME Publishing Company 2023-07-18 2023-07-31 /pmc/articles/PMC10413032/ /pubmed/37577324 http://dx.doi.org/10.21037/tlcr-23-329 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Ulas, Ezgi B. Bahce, Idris Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? |
| title | Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? |
| title_full | Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? |
| title_fullStr | Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? |
| title_full_unstemmed | Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? |
| title_short | Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? |
| title_sort | neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413032/ https://www.ncbi.nlm.nih.gov/pubmed/37577324 http://dx.doi.org/10.21037/tlcr-23-329 |
| work_keys_str_mv | AT ulasezgib neoadjuvantimmunochemotherapyinresectablenonsmallcelllungcancerthemorecyclesthebetter AT bahceidris neoadjuvantimmunochemotherapyinresectablenonsmallcelllungcancerthemorecyclesthebetter |